Certara (CERT) Financials: History & Chart

Certara, Inc.(CERT)

Medical - Healthcare Information Services · Radnor, PA

$10.06-0.01 (-0.10%)

Delayed quote: Oct 6, 2026, 9:30 AM EDT

About Certara, Inc.

Certara, Inc. provides advanced software solutions and technology-driven services, specializing in biosimulation throughout the entire drug development lifecycle. From initial drug discovery and preclinical research to clinical trials, regulatory submissions, and market entry, the company's core mission is to accelerate the delivery of new medicines to patients by transforming these processes with its innovative biosimulation software and expertise. Its extensive portfolio of technology-enabled services includes mechanistic and empirical biosimulation, strategic guidance for drug development and regulatory affairs, clinical pharmacology, model-based meta-analysis, specialized regulatory writing and medical communications, regulatory operations support, and market access consultation. Furthermore, Certara offers a robust suite of software platforms covering mechanistic and empirical PK/PD biosimulation, data standardization and compliance, scientific informatics, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions, and market access communication. The company's clientele primarily comprises biopharmaceutical firms, academic institutions, and governmental organizations. Established in 2008 and headquartered in Princeton, New Jersey, Certara maintains a significant global presence, with operations spanning numerous countries including the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China.

Radnor, PA

1,546 employees

www.certara.com

Healthcare / Medical - Healthcare Information Services

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO: Jon Resnick

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	408.45M	93.27M	106.92M	103.65M	104.62M	104.57M	106.00M	100.36M	94.82M
Cost of Goods Sold	170.21M	35.12M	56.20M	39.17M	39.72M	40.72M	41.52M	38.26M	37.19M
Gross Profit	238.24M	58.15M	50.72M	64.48M	64.90M	63.85M	64.48M	62.10M	57.63M
Gross Profit Margin	58.3%	62.3%	47.4%	62.2%	62.0%	61.1%	60.8%	61.9%	60.8%
Total Operating Expenses	230.64M	58.34M	46.77M	63.64M	61.89M	54.30M	56.86M	56.09M	55.04M
Research & Development	43.54M	9.71M	12.29M	11.28M	10.27M	8.97M	10.52M	7.77M	8.27M
Selling, General & Administrative	155.20M	36.91M	42.73M	37.91M	37.65M	31.18M	32.37M	34.34M	33.38M
Operating Income (EBIT)	7.59M	-196K	3.95M	836K	3.00M	9.55M	7.62M	6.00M	2.59M
Operating Margin	1.9%	-0.2%	3.7%	0.8%	2.9%	9.1%	7.2%	6.0%	2.7%
Income Before Tax (EBT)	-17.51M	-6.39M	-7.94M	-2.91M	-267K	6.25M	4.54M	2.18M	-1.66M
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	39.32M	-4.99M	4.94M	34.36M	5.01M	4.80M	4.81M	5.00M	5.19M
Other Income/Expense	-25.10M	-6.19M	-11.89M	-3.75M	-3.27M	-3.30M	-3.08M	-3.82M	-4.25M
Net Income	-68.40M	-55.27M	-8.76M	-5.89M	1.52M	-1.97M	4.74M	6.58M	-1.37M
Income Tax Expense	1.71M	-307K	820K	2.98M	-1.79M	8.22M	-201K	-4.40M	-290K
Net Profit Margin	-16.7%	-59.3%	-8.2%	-5.7%	1.5%	-1.9%	4.5%	6.6%	-1.4%
EBITDA	59.06M	13.06M	23.04M	1.33M	21.63M	28.37M	26.24M	24.22M	3.03M
EBITDA Margin	14.5%	14.0%	21.5%	1.3%	20.7%	27.1%	24.8%	24.1%	3.2%
Depreciation & Amortization	51.47M	13.25M	19.09M	498K	18.63M	18.82M	18.61M	18.22M	439K
EPS Basic	-0.44	-0.36	-0.06	-0.04	0.01	-0.01	0.03	0.04	-0.01
EPS Diluted	-0.44	-0.36	-0.06	-0.04	0.01	-0.01	0.03	0.04	-0.01
Weighted Average Basic Shares	154.36M	154.36M	157.75M	160.39M	160.40M	160.92M	161.00M	160.89M	160.64M
Weighted Average Diluted Shares	154.36M	154.36M	157.75M	160.39M	160.60M	160.92M	161.35M	161.27M	160.64M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	418.84M	385.15M	354.34M	335.64M	286.10M	243.53M	208.51M	163.72M
Cost of Goods Sold	161.13M	154.52M	141.02M	132.58M	111.62M	100.77M	79.77M	71.04M
Gross Profit	257.71M	230.63M	213.31M	203.07M	174.49M	142.76M	128.74M	92.68M
Gross Profit Margin	61.5%	59.9%	60.2%	60.5%	61.0%	58.6%	61.7%	56.6%
Total Operating Expenses	236.70M	232.36M	254.09M	170.55M	160.91M	167.19M	109.13M	97.33M
Research & Development	41.04M	37.10M	34.17M	28.20M	20.38M	19.64M	11.63M	10.48M
Selling, General & Administrative	139.10M	120.97M	127.41M	99.18M	99.68M	107.68M	58.66M	52.81M
Operating Income (EBIT)	21.02M	-1.73M	-40.77M	32.52M	13.58M	-24.42M	19.61M	-4.65M
Operating Margin	5.0%	-0.4%	-11.5%	9.7%	4.7%	-10.0%	9.4%	-2.8%
Income Before Tax (EBT)	7.62M	-17.18M	-55.14M	18.75M	-3.38M	-50.18M	-9.15M	-32.56M
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	19.74M	21.52M	22.92M	17.77M	16.84M	25.30M	28.00M	27.80M
Other Income/Expense	-13.40M	-15.45M	-14.37M	-13.77M	-16.95M	-25.76M	-28.76M	-27.91M
Net Income	-1.59M	-12.05M	-55.36M	14.73M	-13.27M	-49.40M	-8.93M	-33.26M
Income Tax Expense	9.21M	-5.13M	214K	4.02M	9.89M	-784K	-225K	697K
Net Profit Margin	-0.4%	-3.1%	-15.6%	4.4%	-4.6%	-20.3%	-4.3%	-20.3%
EBITDA	77.57M	66.30M	15.30M	84.99M	58.69M	18.33M	61.17M	32.36M
EBITDA Margin	18.5%	17.2%	4.3%	25.3%	20.5%	7.5%	29.3%	19.8%
Depreciation & Amortization	56.56M	68.03M	56.07M	52.47M	45.12M	42.75M	41.56M	37.01M
EPS Basic	-0.01	-0.08	-0.35	0.09	-0.09	-0.32	-0.06	-0.25
EPS Diluted	-0.01	-0.08	-0.35	0.09	-0.09	-0.32	-0.06	-0.25
Weighted Average Basic Shares	160.39M	160.39M	158.94M	156.88M	149.84M	152.98M	157.34M	132.41M
Weighted Average Diluted Shares	160.39M	160.39M	158.94M	159.35M	149.84M	152.98M	157.34M	132.41M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.